Egg Freezing in Ahmedabad: Who Should Consider It and When
In short: Egg freezing (oocyte cryopreservation) retrieves and freezes a woman’s eggs for possible future use in IVF. Both the number of eggs retrieved and their eventual chance of a live birth depend heavily on age at freezing, which is why age, not urgency, is the central factor fertility specialists discuss when counseling women on timing and realistic expectations.
What egg freezing is
Egg freezing, medically known as oocyte cryopreservation, retrieves eggs after a short course of hormonal stimulation and freezes them for possible future use, usually through IVF with intracytoplasmic sperm injection (ICSI) at the time of thaw. Since the introduction of vitrification, an ultra-rapid freezing technique that avoids the ice-crystal damage seen with older slow-freezing methods, it has become the standard way to freeze eggs specifically, as distinct from freezing embryos or ovarian tissue. Whether it is the right option depends on why it is being considered, a woman’s age, and her ovarian reserve.
Two different conversations: elective preservation and medical fertility preservation
“Egg freezing” covers two clinically distinct situations that deserve two different conversations.
The first is planned or elective oocyte cryopreservation: a woman with no medical urgency freezes eggs to preserve reproductive options while she is not yet ready, or not yet able, to try to conceive. The American Society for Reproductive Medicine (ASRM) Ethics Committee considers this ethically permissible, while stating plainly that patients should be counseled about the real uncertainties in its long-term efficacy, since the approach is still relatively new and evolving.
The second is medical fertility preservation: freezing eggs before a treatment likely to affect ovarian function, most often chemotherapy or pelvic radiotherapy for cancer, but also some long-term treatments for autoimmune disease, certain genetic conditions linked to earlier loss of ovarian reserve, and occasionally before planned ovarian surgery, including some endometriosis-related surgery, which can itself reduce ovarian reserve. This conversation is usually time-pressured and coordinated closely with the treating specialist rather than planned months in advance.
The underlying procedure, stimulation, retrieval, vitrification, is identical either way. What differs is urgency, timeline, and often the starting ovarian reserve involved.
Why timing matters
Egg supply is set before birth and only ever declines: from roughly 6–7 million follicles in fetal life, to about 1 million at birth, to around 25,000 by age 37, to roughly 1,000 — near the threshold generally associated with menopause, by age 51. The proportion of chromosomally normal eggs also falls with age. Together, published estimates suggest natural per-cycle fertility is modestly lower in the early thirties than the early twenties (on the order of 15–19%), meaningfully lower by the late thirties (roughly a quarter to almost half), and substantially lower, around 95% — by the early forties.
This is a population-level pattern, not a prediction for any individual, ovarian reserve varies widely between women of the same age, which is why timing is best discussed as probability and planning rather than a fixed deadline. For egg freezing specifically, age affects both how many eggs a stimulation cycle is likely to yield and the eventual chance any one frozen egg leads to a live birth.
Why age is the dominant factor: ovarian reserve, AMH, and antral follicle count
Ovarian reserve is estimated two main ways: a blood test for anti-Müllerian hormone (AMH), a hormone produced by small ovarian follicles, and an ultrasound antral follicle count (AFC) taken early in the menstrual cycle. Per ASRM guidance, both are the preferred tests for one specific purpose, predicting how many eggs a stimulation cycle is likely to yield. In one study of over 3,000 first stimulation cycles, the median number of eggs retrieved was 18 in women under 30, falling in a roughly linear pattern to a median of 8 by age 44 and older.
What AMH and AFC do not reliably do is predict a woman’s overall reproductive potential independent of her age. ASRM’s committee opinion on ovarian reserve testing states plainly that these markers are useful predictors of oocyte yield after stimulation but are poor predictors of reproductive potential on their own. A reassuring result does not offset the effect of age, and a lower-than-average result at a young age does not mean pregnancy is unlikely. Ovarian reserve testing is one input into an individualized conversation, not a stand-alone verdict, age remains the strongest single predictor of eventual egg quality.
What egg freezing actually involves: the process, step by step
- Baseline assessment. Blood tests (including AMH), a pelvic ultrasound for antral follicle count, and a general health history, used to individualize the stimulation plan.
- Ovarian stimulation. Daily hormone injections, typically for around 7 to 12 days, encourage several follicles to develop together rather than the single follicle that matures naturally each month.
- Monitoring. Ultrasound scans and blood hormone checks every few days through the stimulation phase, so the medication dose can be adjusted and timing judged accurately.
- The trigger. Once enough follicles reach an appropriate size, a trigger medication completes egg maturation ahead of retrieval.
- Egg retrieval. A day-care procedure done under sedation, with eggs collected by needle aspiration under ultrasound guidance, usually about 36 hours after the trigger, taking under 30 minutes.
- Vitrification. Mature eggs are frozen within hours of retrieval using vitrification, then moved into frozen storage.
Not every egg collected is mature enough to freeze; this is discussed individually rather than promised in advance.
The process timeline: what to expect, week by week
For most women, a single cycle, from the first stimulation injection to the retrieval procedure, takes about two weeks, with monitoring visits every two to three days. Before that, an initial consultation and baseline testing plan the cycle, usually timed to begin early in a menstrual cycle. After retrieval, most women resume normal activity within a few days, though brief bloating or mild discomfort is common.
Some women choose more than one stimulation cycle to bank more eggs relative to their age, usually spaced by a full menstrual cycle. Where genuine urgency exists, a limited window before chemotherapy, for instance, back-to-back stimulation within one cycle (“dual stimulation”) is sometimes used to gain time. Whether more than one cycle is worthwhile is an individual decision made with a specialist, not a default recommendation.
Who it suits
There is no single profile of a woman for whom egg freezing is “recommended,” and it is not something to pursue reflexively. Suitability is assessed case by case, age, ovarian reserve, health history, and which of the two conversations above applies.
Within elective, age-related preservation, common candidates are women not currently positioned to try to conceive, because of relationship circumstances, career or education timing, or health reasons unrelated to fertility, who want that decision informed by their own ovarian reserve and age rather than left to chance.
Within medical fertility preservation, candidates typically include women about to start chemotherapy or pelvic radiotherapy, some beginning long-term gonadotoxic treatment for autoimmune conditions, women with genetic conditions linked to early loss of ovarian reserve, and occasionally women facing ovarian surgery, including some endometriosis-related surgery. Here the decision sits alongside, not instead of, the primary treatment plan, coordinated with the treating specialist.
Neither list is exhaustive, and neither replaces an individual consultation.
Setting realistic expectations
This is the section where honesty matters most. ASRM’s Ethics Committee is explicit that planned oocyte cryopreservation is not a guarantee of a future live birth, and that patients should be counseled about the real uncertainties in its efficacy before proceeding. No clinic, in Ahmedabad or anywhere else, can promise a specific number of eggs, embryos, or a future pregnancy.
The evidence does show a consistent, age-dependent pattern. An early individual patient data meta-analysis estimated that, for a 30-year-old with a handful of eggs thawed, the modeled chance of live birth per cycle ranged from roughly 9–11% using older slow-freezing methods to roughly 21–24% using vitrification, figures from an earlier era of the technique, in women already being treated for infertility, so outcomes with modern vitrification in healthier, elective-preservation populations are generally expected to be more favorable, though centre-specific data remain limited. A more recent clinical review estimated the overall chance of a single vitrified, warmed egg becoming a live-born child at around 6.5% — ranging from about 7.4% in women under 30 to about 5.2% in women 38 and older.
Because the chance per egg is real but modest, the number of eggs banked matters as much as the freezing itself. One counseling model estimates that a woman freezing eggs at 35 or younger may need around 10 mature eggs banked for a 70% modeled chance of at least one live birth, compared with roughly 20 mature eggs at 38 — and more again at older ages. These are population-level estimates, not individual predictions, but the direction is consistent and worth understanding before a cycle begins, not after.
More detail on the evidence behind these numbers
These figures come from different types of study, each with its own limitations. Cil, Bang and Oktay (2013) pooled 2,265 freeze-thaw cycles from 1,805 women across ten studies using both slow-freezing and vitrification, and remains one of the only studies to model live birth probability directly against age, freezing method, and number of eggs thawed. The authors themselves noted the underlying population was already being treated for infertility, so outcomes for healthy women pursuing elective preservation may differ, though this hasn’t been proven directly, since relatively few women who elect to freeze eggs have yet returned to use them in large numbers.
The “number needed” counseling model (Goldman et al., 2017) was built from women with normal ovarian reserve undergoing IVF for male-factor or tubal infertility, combined with age-specific chromosomal-normalcy data, to estimate probabilities specifically for elective egg freezing. Its full modeled figures: roughly 10 mature eggs at or before 35, 20 at 38, 35 at 40, and 55 at 42, for a 70% chance of at least one live birth. A separate cohort study (Doyle et al., 2016) found meaningfully higher clinical pregnancy rates in frozen-egg IVF cycles performed before age 38 than at or after it (60.2% versus 43.9% in that cohort). ASRM itself states that while outcomes are, on average, more favorable at a younger age, there is not enough evidence to fix one universal “ideal age” that applies to every woman, which is why this is discussed as a personalized, evidence-informed decision rather than a fixed rule.
Risks in balanced terms: understanding ovarian hyperstimulation syndrome (OHSS)
The main risk specific to the stimulation phase of egg freezing is ovarian hyperstimulation syndrome (OHSS) — an exaggerated ovarian response to the stimulation medication. It is real and worth understanding, and for the great majority of women it is also mild and self-limited. Mild symptoms, such as bloating or mild discomfort, can occur in up to roughly one in five stimulated cycles; the moderate or severe forms that need closer medical attention are considerably less common, well under one in twenty cycles, and serious complications are uncommon with appropriate monitoring.
What makes OHSS manageable is that the main risk factors, a high AMH or antral follicle count, polycystic ovary syndrome, lower body weight, and a larger-than-average number of developing follicles, are known in advance, which is exactly why stimulation doses are individualized and monitored throughout the cycle rather than fixed from the start. For egg-freezing cycles specifically, there is an additional, well-studied safeguard: because no fresh embryo transfer is planned in the same cycle, clinics can use a GnRH-agonist trigger instead of the conventional hCG trigger for women identified as higher risk. Trial-level evidence shows this substantially lowers OHSS rates compared with hCG, without the trade-offs an agonist trigger can carry when a fresh transfer is involved, since egg freezing involves none.
Egg retrieval itself is also a low-risk outpatient procedure; published data put major complications (bleeding, infection, or injury to nearby structures) at under 1% of retrievals.
Risk factors and monitoring in more detail
OHSS results from fluid shifting out of the blood vessels in response to the stimulation process, causing bloating, mild nausea, and abdominal discomfort in milder cases. More significant cases are uncommon but can involve marked fluid accumulation and need prompt medical attention, a reason for close monitoring, not for alarm. Recognized risk factors include AMH above roughly 3.3 ng/mL, antral follicle count above about 8, elevated estradiol levels during stimulation, polycystic ovary syndrome, lower body-mass index, and retrieval of a large number of eggs. Associated risks such as ovarian torsion or blood clots are further reduced when OHSS itself is prevented, and remain uncommon overall.
A 2014 Cochrane systematic review of randomized trials found that using a GnRH-agonist trigger instead of hCG reduced the odds of any degree of OHSS by roughly 85% in fresh IVF cycles, and specifically noted this approach as useful for women freezing eggs for fertility preservation, precisely because no fresh embryo transfer needs to be protected in that cycle.
What proper counseling should include before you proceed
Egg freezing is a significant, personal decision, and the conversation preceding it should support informed decision-making, not persuasion. The European Society of Human Reproduction and Embryology (ESHRE) guideline is specific on this point: women considering oocyte cryopreservation should be fully informed about realistic success rates, the risks involved, the benefits, and possible long-term physical and psychological consequences, before a cycle is started.
In practice, that conversation should cover: your age and ovarian reserve findings, and what they do and do not predict; a realistic, individualized sense of likely egg yield and what it means statistically; your personal OHSS risk and how it will be monitored; whether one cycle is likely to be enough, or whether more than one is worth discussing; and, for medical fertility preservation, direct coordination with your treating specialist on timing. Psychological support should be offered as part of this conversation, not treated as an afterthought, particularly where the decision is being made under time pressure. Suitability is always assessed case by case; a good counseling conversation should leave you able to make your own decision, questions answered, rather than steered toward one.
Egg freezing and fertility preservation in Ahmedabad
At Balaji Horizon Women’s Hospital in Ahmedabad, fertility preservation is addressed within a broader reproductive medicine and IVF program led by Dr. Priyadatt Patel, alongside his work in advanced laparoscopic surgery and endometriosis care. In practice, that means a fertility preservation question, whether it begins with age-related planning, a new diagnosis requiring urgent coordination with an oncologist, or a planned ovarian surgery, can be discussed by a team already familiar with the relevant reproductive-medicine and surgical considerations, rather than requiring separate, disconnected opinions.
A first conversation typically covers personal and family history, an ovarian reserve assessment (AMH and antral follicle count), and a discussion of your goals and timeline, before any stimulation cycle is planned. Where a new medical diagnosis is the reason for considering egg freezing, coordination with your treating physician on timing is built into that same conversation. For how fertility preservation fits within the hospital’s broader reproductive medicine services, see the fertility preservation program overview.
Frequently asked questions
What is the best age for egg freezing?
How many eggs should I freeze?
Does a normal AMH or antral follicle count mean I will definitely conceive later?
Is egg freezing the same whether it’s elective or before cancer treatment?
Is ovarian hyperstimulation syndrome (OHSS) a common risk with egg freezing?
Reviewed by Dr. Priyadatt Patel, MBBS, MS — last reviewed 17 August 2026
This article is written for general patient education and does not replace an individualized medical consultation; please discuss your personal health history, goals, and options with a qualified fertility specialist.
Free Patient Guide
The Fertility Preservation Primer
What egg freezing actually is, who it helps, and how to decide. Honest age-stratified numbers, realistic costs, and questions to ask in your consultation.
Get the guide →